An evaluation of the completeness of reporting of childhood tuberculosis

S S S Teo1, M Alfaham, M R Evans

  • 1Centre for Child Health, University of London, London, UK.

Insights

The Enhanced Tuberculosis Surveillance (ETS) scheme significantly under-reports childhood tuberculosis cases, particularly in children under five. Improved reporting is crucial for accurate public health planning and resource allocation.

Area of Science:

  • Public Health
  • Epidemiology
  • Pediatrics

Background:

  • The sensitivity of the Enhanced Tuberculosis Surveillance (ETS) scheme for monitoring pediatric tuberculosis in the UK is not well-established.
  • Accurate surveillance data is essential for effective public health interventions and resource allocation for tuberculosis control.

Purpose of the Study:

  • To evaluate the sensitivity of the Enhanced Tuberculosis Surveillance (ETS) scheme in capturing pediatric tuberculosis cases in the UK.
  • To identify demographic factors influencing reporting rates within the ETS scheme.

Main Methods:

  • A prospective observational study was conducted using the British Paediatric Surveillance Unit (BPSU) reporting scheme.
  • Paediatric tuberculosis cases reported to the BPSU between January and December 2004 were matched with records from the ETS database.
  • Sensitivity was assessed by comparing case ascertainment between the two surveillance systems.

Main Results:

  • Out of 320 cases reported to the BPSU, an estimated 557 pediatric tuberculosis cases occurred in England, Wales, and Northern Ireland in 2004.
  • 40% of cases were reported to both BPSU and ETS, 18% to BPSU only, and 42% to ETS only.
  • Children under 5 years were significantly less likely to be reported to ETS compared to older children (p<0.01).

Conclusions:

  • There is substantial under-reporting of childhood tuberculosis, with the ETS missing approximately 20% of cases.
  • The ETS scheme may miss a disproportionately higher number of tuberculosis cases in children under 5 years.
  • Enhanced efforts are required to improve the completeness of the ETS for pediatric tuberculosis surveillance and inform resource allocation.

Related Concept Videos

Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...